SEATTLE & INNSBRUCK, Austria--(BUSINESS WIRE)--Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback